Santa Clara, California -- Medical device maker Miramar Labs has secured $2 million in venture capital debt investment, according to an SEC regulatory filing.
Miramar has developed a new treatment to treat excessive underarm sweating.
Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.
A total of 5 investors participated in the offering.
Miramar is still seeking $681,000 in additional debt financing, according to the filing.